Ciclosporin to Reduce Reperfusion Injury in Primary PCI

NCT02390674 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Reperfusion Injury

Interventions

DRUG: Ciclosporin
DRUG: Saline

Sponsor

Newcastle-upon-Tyne Hospitals NHS Trust

Collaborators

[object Object]
[object Object]